Anti-CCP, IgA, IgM, and RF-positive RA patients exhibit higher calprotectin levels as compared to the control groups that correlates with the baseline levels of inflammation markers, CRP, ESR, and anti-CCP (163). This evidence concerns the gene CD40LG and rheumatoid arthritis.